Biblio
Export 98 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is Q [Clear All Filters]
“Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, 2018.
, “Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 61-69, 2018.
, “Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 61-69, 2018.
, “Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.”, J Alzheimers Dis, vol. 65, no. 1, pp. 243-263, 2018.
, “Inhibition of Histone Acetylation by ANP32A Induces Memory Deficits.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1537-1546, 2018.
, “Learning Processes and Brain Connectivity in A Cognitive-Motor Task in Neurodegeneration: Evidence from EEG Network Analysis.”, J Alzheimers Dis, vol. 66, no. 2, pp. 471-481, 2018.
, “The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 951-961, 2018.
, “Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.”, J Alzheimers Dis, vol. 64, no. s1, pp. S33-S39, 2018.
, “Methylenetetrahydrofolate Reductase Deficiency Deregulates Regional Brain Amyloid-β Protein Precursor Expression and Phosphorylation Levels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 223-237, 2018.
, “Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
, “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
, “Role of Blood-Brain Barrier in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1223-1234, 2018.
, “SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.”, J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
, “SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.”, J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
, “Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.”, J Alzheimers Dis, vol. 65, no. 1, pp. 293-302, 2018.
, “Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 989-1000, 2018.
, “Stereological Investigation of the Effects of Treadmill Running Exercise on the Hippocampal Neurons in Middle-Aged APP/PS1 Transgenic Mice.”, J Alzheimers Dis, vol. 63, no. 2, pp. 689-703, 2018.
, “Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide.”, J Alzheimers Dis, vol. 63, no. 1, pp. 283-301, 2018.
, “Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.”, J Alzheimers Dis, vol. 63, no. 1, pp. 13-33, 2018.
, “A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 107-115, 2018.
, “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
, “Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.”, J Alzheimers Dis, vol. 75, no. 1, pp. 119-138, 2020.
, “The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1455-1466, 2020.
, “The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1455-1466, 2020.
, “Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.”, J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.
,